The DOI matches its Crossref record; 270 of the 270 references it cites were found in a registry or an index.
The next generation of therapeutics for chronic kidney disease
Open accessAbstract
Chronic kidney disease (CKD) represents a leading cause of death in the United States. There is no cure for this disease, with current treatment strategies relying on blood pressure control through blockade of the renin–angiotensin system. Such approaches only delay the development of end-stage kidney disease and can be associated with serious side effects. Recent identification of several novel mechanisms contributing to CKD development — including vascular changes, loss of podocytes and renal epithelial cells, matrix deposition, inflammation and metabolic dysregulation — has revealed new potential therapeutic approaches for CKD. This Review assesses emerging strategies and agents for CKD treatment, highlighting the associated challenges in their clinical development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–270 of 270
Eberlein, C. A., Kendrew, J., McDaid, K., Alfred, A., Kang, J., Jacobs, V. N., Ross, S. J., Rooney, C., Smith, N. R., Rinkenberger, J. L., et al. (2012) · Oncogene · doi:10.1038/onc.2012.460 · Cited by 87
Li, S., Mariappan, N., Megyesi, J. K., Shank, B. B., Kannan, K., Theus, S. A., Price, P. M., Duffield, J. S., & Portilla, D. (2013) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00309.2013 · Cited by 86
Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury
Simons, J. L., Provoost, A. P., Anderson, S., Rennke, H. G., Troy, J. L., & Brenner, B. M. (1994) · Kidney International · doi:10.1038/ki.1994.287 · Cited by 83
Rastogi, S., Rizwani, W., Joshi, B., Kunigal, S., & Chellappan, S. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.93 · Cited by 83
Mine, S., Okada, Y., Tanikawa, T., Kawahara, C., Tabata, T., & Tanaka, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.197 · Cited by 82
Rahman, M., Xie, D., Feldman, H., Go, A., He, J., Kusek, J., Lash, J., Miller, E., Ojo, A., Pan, Q., et al. (2014) · American Journal of Nephrology · doi:10.1159/000368915 · Cited by 81
Understanding the Epigenetic Syntax for the Genetic Alphabet in the Kidney
Suszták, K. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013050461 · Cited by 81
Vyas, D., O’Dell, K. M., Bandy, J. L., & Boyce, E. G. (2013) · Annals of Pharmacotherapy · doi:10.1177/1060028013512790 · Cited by 79
A Role for the Endothelial Glycocalyx in Regulating Microvascular Permeability in Diabetes Mellitus
Perrin, R. M., Harper, S. J., & Bates, D. O. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0041-6 · Cited by 78
The Sweet Pee Model for Sglt2 Mutation
Ly, J., Onay, T., Sison, K., Sivaskandarajah, G. A., Sabbisetti, V. S., Li, L., Bonventre, J. V., Flenniken, A. M., Paragas, N., Barasch, J. M., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010080888 · Cited by 75
Measured GFR as “Gold Standard”—All that Glitters Is Not Gold?
Hsu, C., & Bansal, N. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06040611 · Cited by 73
Anti-Inflammatory Effects of the Advanced Glycation End Product Inhibitor LR-90 in Human Monocytes
Figarola, J. L., Shanmugam, N., Natarajan, R. D., & Rahbar, S. (2007) · Diabetes · doi:10.2337/db06-0936 · Cited by 73
Greene, T., Teng, C., Inker, L. A., Redd, A. M., Ying, J., Woodward, M., Coresh, J., & Levey, A. S. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.08.019 · Cited by 70
Lambers Heerspink, H. J., Weldegiorgis, M., Inker, L. A., Gansevoort, R., Parving, H.-H., Dwyer, J. P., Mondal, H., Coresh, J., Greene, T., Levey, A. S., et al. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.09.016 · Cited by 69
A podocentric view of nephrology
Ly, J., Alexander, M. P., & Quaggin, S. E. (2004) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200405000-00006 · Cited by 69
Epithelial Plasticity versus EMT in Kidney Fibrosis
Huang, S., & Suszták, K. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.11.009 · Cited by 69
Measured GFR Does Not Outperform Estimated GFR in Predicting CKD-related Complications
Hsu, C., PROPERT, K. J., Xie, D., Hamm, L. L., He, J., Miller, E. R., OJO, A. O., Shlipak, M. G., Teal, V. L., Townsend, R. R., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010101077 · Cited by 67
Lysophosphatidic acid receptor (LPAR) modulators: The current pharmacological toolbox
Llona‐Minguez, S., Ghassemian, A., & Helleday, T. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.01.004 · Cited by 66
Treatment of Keloid and Hypertrophic Scars by Iontophoretic Transdermal Delivery of Tranilast
Shigeki, S., Murakami, T., Yata, N., & Ikuta, Y. (1997) · Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery · doi:10.3109/02844319709085482 · Cited by 65
Lin, J. H., Zhang, J. J., Lin, S., & Chertow, G. M. (2014) · The Nephron journals/Nephron journals · doi:10.1159/000369152 · Cited by 64
Li, L., Yin, Q., Tang, X., Bai, L., Zhang, J., Gou, S., Zhu, H., Cheng, J., Fu, P., & Liu, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113639 · Cited by 64
Esteghamati, A., Noshad, S., Jarrah, S., Mousavizadeh, M., Khoee, S. H., & Nakhjavani, M. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft281 · Cited by 62
Tsai, C., Wu, C., Lee, J.-K., Chang, S., Kuo, Y., Wang, Y., Lai, L., Chiang, F., Hwang, J., & Lin, J.-L. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv008 · Cited by 62
Effects of sulodexide in patients with type 2 diabetes and persistent albuminuria
Heerspink, H. J. L., Greene, T., Lewis, J. B., et al. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm893 · Cited by 61
Ledó, N., Ko, Y.-A., Park, A. S. D., Kang, H. M., Han, S. Y., Choi, P., & Suszták, K. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014010028 · Cited by 60
The Role of LOX and LOXL2 in Scar Formation After Glaucoma Surgery
Bergen, T. V., Marshall, D. C. L., de Veire, S. V., Vandewalle, E., Moons, L., Herman, J., Smith, V., & Stalmans, I. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-11696 · Cited by 57
Foster, M. C., Inker, L. A., Hsu, C., Eckfeldt, J. H., Levey, A. S., Pavkov, M. E., Myers, B. D., Bennett, P. H., Kimmel, P. L., Vasan, R. S., et al. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.01.013 · Cited by 56
Sonoda, Y., Gohda, T., Suzuki, Y., Omote, K., Ishizaka, M., Matsuoka, J., & Tomino, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122212 · Cited by 56
Complement in glomerular injury
Berger, S. P., & Daha, M. R. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0090-3 · Cited by 54
MicroRNA-21 regulation of the progression of viral myocarditis to dilated cardiomyopathy
Xu, H., DING, Y.-J., ZHANG, Z.-X., Wang, Z., Luo, C., Li, B., Shen, Y., Tao, L., & Zhao, Z. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2205 · Cited by 54
Change in Measured GFR Versus eGFR and CKD Outcomes
Ku, E., Xie, D., Shlipak, M. G., Anderson, A. H., Chen, J., Go, A. S., He, J., Horwitz, E. J., Rahman, M., Ricardo, A. C., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015040341 · Cited by 53
Mouse Podocyte Complement Factor H
Alexander, J. J., Wang, Y., Chang, A., Jacob, A., Minto, A. W., Karmegam, M., Haas, M., & Quigg, R. J. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006101125 · Cited by 52
Outcomes Associated With Microalbuminuria
Kovesdy, C. P., Lott, E. H., Lü, J., Malakauskas, S. M., Ma, J. Z., Molnar, M. Z., & Kalantar‐Zadeh, K. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.11.071 · Cited by 51
Characterization of the human 36-kDa carboxyl terminal LIM domain protein (hCLIM1)
Kotaka, M., Ngai, S. M., Garcia-Barceló, M., Tsui, S. K., Fung, K., Lee, C.-Y., & Waye, M. M. Y. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990201)72:2<181::aid-jcb3>3.0.co;2-d · Cited by 49
The Future of Polycystic Kidney Disease Research—As Seen By the 12 Kaplan Awardees
Antignac, C., Calvet, J. P., Germino, G. G., Grantham, J. J., Guay‐Woodford, L. M., Harris, P. C., Hildebrandt, F., Peters, D. J. M., Somlo, S., Torres, V. E., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014121192 · Cited by 47
Early Microvascular Changes with Loss of the Glycocalyx in Children with Type 1 Diabetes
Nußbaum, C., Heringa, A. C. F., Mormanová, Z., Puchwein-Schwepcke, A., Pozza, S. B., & Genzel‐Boroviczény, O. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.11.016 · Cited by 46
Maile, L. A., Busby, W. H., Sitko, K., Capps, B. E., Sergent, T., Badley-Clarke, J., & Clemmons, D. R. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0241 · Cited by 46
TNF-α Suppresses Prolyl-4-Hydroxylase α1 Expression via the ASK1–JNK–NonO Pathway
Zhang, C., Zhang, M.-X., Shen, Y. H., Burks, J. K., Zhang, Y., Wang, J., LeMaire, S. A., Yoshimura, K., Aoki, H., Coselli, J. S., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.144881 · Cited by 45
Aldosterone Mediates Cardiac Fibrosis in the Setting of Hypertension
Azibani, F., Fazal, L., Chatziantoniou, C., Samuel, J., & Delcayre, C. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0354-3 · Cited by 44
Tuot, D. S., Velásquez, A., McCulloch, C. E., Banerjee, T., Zhu, Y., Hsu, C., Handley, M. A., Schillinger, D., & Powe, N. R. (2015) · BMC Nephrology · doi:10.1186/s12882-015-0168-4 · Cited by 44
A Purpose-Synthesised Anti-Fibrotic Agent Attenuates Experimental Kidney Diseases in the Rat
Gilbert, R. E., Zhang, Y., Williams, S. J., Zammit, S. C., Stapleton, D., Cox, A. J., Krum, H., Langham, R. G., & Kelly, D. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047160 · Cited by 43
Ruilope, L. M., Agarwal, R., Chan, J. C. N., Cooper, M. E., Gansevoort, R. T., Haller, H. G., Remuzzi, G., Rossing, P. R., Schmieder, R. E., Nowack, C., et al. (2014) · American Journal of Nephrology · doi:10.1159/000371497 · Cited by 43
Phosphodiesterase type 5 inhibitors and kidney disease
Afşar, B., Ortíz, A., Covic, A. C., Gaipov, A., Esen, T., Goldsmith, D. J. A., & Kanbay, M. (2015) · International Urology and Nephrology · doi:10.1007/s11255-015-1071-4 · Cited by 42
Maile, L. A., Busby, W. H., Nichols, T. C., Bellinger, D. A., Merricks, E. P., Rowland, M., Veluvolu, U., & Clemmons, D. R. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000476 · Cited by 41
Zhang, Z., Shahinfar, S., Keane, W. F., Ramjit, D. R., Dickson, T. Z., Gleim, G. W., Mogensen, C. E., de Zeeuw, D., Brenner, B. M., & Snapinn, S. M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004080632 · Cited by 39
The mitochondrial and kidney disease phenotypes of kd/kd mice under germfree conditions
Hallman, T., Peng, M., Meade, R., Hancock, W. W., Madaio, M. P., & Gasser, D. L. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.10.006 · Cited by 36
Schievink, B., de Zeeuw, D., Smink, P. A., Andress, D. L., Brennan, J. J., Coll, B., Correa‐Rotter, R., Hou, F. F., Kohan, D. E., Kitzman, D. W., et al. (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487315598709 · Cited by 35
Fox, C. H., Vest, B. M., Kahn, L. S., Dickinson, L. M., Fang, H., Pace, W. D., Kimminau, K. S., Vassalotti, J. A., Loskutova, N., & PETERSON, K. A. (2013) · Implementation Science · doi:10.1186/1748-5908-8-88 · Cited by 33
Dwyer, J. P., Greco, B., Umanath, K., et al. (2014) · The Nephron journals/Nephron journals · doi:10.1159/000369310 · Cited by 32
Yamada, H. (1995) · Journal of Dermatological Science · doi:10.1016/0923-1811(94)00355-i · Cited by 31
Intensive Glycemic Control and Cardiovascular Disease Observations From the ACCORD Study
Cefalu, W. T., & Watson, K. E. (2008) · Diabetes · doi:10.2337/db08-0220 · Cited by 31
Zhou, Y.-H., Tang, L.-G., Guo, S.-L., Jin, Z.-C., Wu, M.-J., Zang, J., Xu, J., Wu, C.-F., Qin, Y.-Y., Cai, Q., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018788 · Cited by 30
KIM-1 expression predicts renal outcomes in IgA nephropathy
Kwon, S. H., Park, M. Y., Jeon, J. S., Noh, H., Choi, S. J., Kim, J. K., Hwang, S. D., Jin, S. Y., & Han, D. C. (2012) · Clinical and Experimental Nephrology · doi:10.1007/s10157-012-0707-2 · Cited by 27
Methods Used in Economic Evaluations of Chronic Kidney Disease Testing — A Systematic Review
Sutton, A. J., Breheny, K., Deeks, J. J., Khunti, K. K., Sharpe, C. C., Ottridge, R. S., Stevens, P. E., Cockwell, P., Kalra, P. A., Lamb, E. J., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140063 · Cited by 27
Beyond Statins: New Lipid Lowering Strategies to Reduce Cardiovascular Risk
Noto, D., Cefalu, A. B., & Averna, M. R. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0414-4 · Cited by 26
BlockingαVβ3 Integrin Ligand Occupancy Inhibits the Progression of Albuminuria in Diabetic Rats
Maile, L. A., Gollahon, K. A., Wai, C., Dunbar, P. R., Busby, W. H., & Clemmons, D. R. (2014) · Journal of Diabetes Research · doi:10.1155/2014/421827 · Cited by 26
An update of the blockade of the renin angiotensin aldosterone system in clinical practice
Márquez, D. F., Ruiz‐Hurtado, G., Ruilope, L. M., & Segura, J. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1079623 · Cited by 26
Dunn, B. R., Zatz, R., Rennke, H. G., Meyer, T. W., Anderson, S., & Brenner, B. M. (1986) · PubMed · Cited by 24
ADCK4 “reenergizes” nephrotic syndrome
Málaga-Diéguez, L., & Suszták, K. (2013) · Journal of Clinical Investigation · doi:10.1172/jci73168 · Cited by 23
Hosohata, K., Ando, H., Takeshita, Y., Misu, H., Takamura, T., Kaneko, S., & Fujimura, A. (2014) · Diabetes and Vascular Disease Research · doi:10.1177/1479164114531299 · Cited by 23
A Possible Role of Galectin-9 in the Pulmonary Fibrosis of Patients with Interstitial Pneumonia
Matsumoto, N., Katoh, S., Yanagi, S., Arimura, Y., Tokojima, M., Ueno, M., Hirashima, M., & Nakazato, M. (2013) · Lung · doi:10.1007/s00408-012-9446-0 · Cited by 21
Hansen, H. G., Overgaard, A. J., Lajer, M., Hubálek, F., Højrup, P., Pedersen, L., Tarnow, L., Rossing, P. R., Pociot, F., & McGuire, J. N. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200900169 · Cited by 21
Xiang, X., JIANG, T.-P., ZHANG, S., et al. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3403 · Cited by 20
Saito, M., Takada, M., Hirooka, K., Isobe, F., & Yasumura, Y. (2005) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2005.00694.x · Cited by 19
Barton, M., Mullins, J. J., Bailey, M. A., & Kretzler, M. (2006) · Hypertension · doi:10.1161/01.hyp.0000245138.09687.8a · Cited by 18
MCP-1 and MIP-2 expression and production in BB diabetic rat: Effect of chronic hypoxia
Cacchio, M., Lucci, I., Giulio, C. D., Bianchi, G., Grilli, A., Patruno, A., & Reale, M. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-3556-4 · Cited by 17
Heerspink, H. J. L. (2011) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2011.04.001 · Cited by 16
Porte, J., & Jenkins, G. R. (2014) · Pharmacology Research & Perspectives · doi:10.1002/prp2.30 · Cited by 14
ASK1–JNK signaling cascade mediates Ad‐ST13‐induced apoptosis in colorectal HCT116 cells
Yang, M., Yu, M., Guan, D., Gu, J., Cao, X., Wang, W., Zheng, S. S., Xu, Y., Shen, Z., & Liu, X. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22551 · Cited by 9
67th Annual Meeting of the American Diabetes Association
Colca, J. R. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.10.1735 · Cited by 8
Cited by
KDIGO 2020 Clinical practice guideline for diabetes management in chronic kidney disease
de Boer, I. H., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.06.019 · Cited by 1,399
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.008 · Cited by 1,373
Mitochondrial Damage and Activation of the STING Pathway Lead to Renal Inflammation and Fibrosis
Chung, K. W., Dhillon, P., Huang, S., Sheng, X., Shrestha, R., Qiu, C., Kaufman, B. A., Park, J., Pei, L., Baur, J., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.08.003 · Cited by 651
Self-citationSignaling pathways of chronic kidney diseases, implications for therapeutics
Yuan, Q., Tang, B., & Zhang, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01036-5 · Cited by 453
The fibrogenic niche in kidney fibrosis: components and mechanisms
Li, L., Fu, H., & Liu, Y. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00590-z · Cited by 440
Metadata
- Authors
- Breyer, M. D., & Susztak, K.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2016-05-27
- Volume
- 15
- Issue
- 8
- Pages
- 568-588
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2401600644
- Cited by
- 272
- References
- 270
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.